Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company National Institutes of Health
DescriptionHumanized mAb targeting the CD4 binding site of HIV-1 using Xencor's Xtend Fc Domain technology
Molecular Target CD4
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation
PartnerXencor Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today